Literature DB >> 313350

[Indirect assessment of exocrine pancreatic function by oral administration of a synthetic peptide, N-benzoyl-L-tyrosyl-para-amino-benzoic-acid (PABA test) (author's transl)].

A Ribet, J Frexinos, J Escourrou, N Vaysse, Y Arany, M Varignon.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1979        PMID： 313350

Source DB:  PubMed          Journal:  Gastroenterol Clin Biol        ISSN： 0399-8320


× No keyword cloud information.
  7 in total

1.  Comparison of BT-PABA test and fecal chymotrypsin measurements in normal subjects and diabetic patients.

Authors:  G Montalto; A Carroccio; G Marino; M Soresi; C Di Marco; A Notarbartolo
Journal:  Acta Diabetol Lat       Date:  1990 Apr-Jun

2.  BT-PABA test with plasma PABA measurements: evaluation of sensitivity and specificity.

Authors:  J C Delchier; J C Soule
Journal:  Gut       Date:  1983-04       Impact factor: 23.059

3.  Histological variations of the duodenal mucosa in chronic human pancreatitis.

Authors:  F Senegas-Balas; M J Bastie; D Balas; J Escourrou; G Bommelaer; C Bertrand; Y Arany; A Ribet
Journal:  Dig Dis Sci       Date:  1982-10       Impact factor: 3.199

4.  Value of serum PABA as a pancreatic function test.

Authors:  C Lang; K Gyr; I Tonko; D Conen; G A Stalder
Journal:  Gut       Date:  1984-05       Impact factor: 23.059

5.  BT-Paba test in the diagnosis of pancreatic exocrine insufficiency in cystic fibrosis: urinary and serum determinations compared.

Authors:  S Bellentani; A Grisendi; M Rinaldi; P Bertolani; G Costa; M Agostini; G Mastella; F Balli; F Manenti
Journal:  Eur J Pediatr       Date:  1984-12       Impact factor: 3.183

6.  Preliminary evaluation of a single-day tubeless test of pancreatic function.

Authors:  C J Mitchell; H P Field; F G Simpson; A Parkin; J Kelleher; M S Losowsky
Journal:  Br Med J (Clin Res Ed)       Date:  1981-05-30

7.  Diagnostic and therapeutic applications of bentiromide screening test for exocrine pancreatic insufficiency in patients with cystic fibrosis. Comparison with other tests of exocrine pancreatic disease.

Authors:  V S Hubbard; R O Wolf; L A Lester; A C Egge
Journal:  Dig Dis Sci       Date:  1984-10       Impact factor: 3.199
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.